Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jason R Fangusaro
Pediatric Brain Tumor Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
- Children'S Memorial Outpatient Center in Lincoln Park
Chicago, Illinois, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- National Institutes of Health Clinical Center
Bethesda, Maryland, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Jul 2010
- Primary completion
- 17 Jan 2026
- Completion
- 18 Mar 2027
- Last update posted
- 13 May 2026
- Registered enrollment
- 217
- Registry id
- NCT01089101
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.